» Articles » PMID: 34984171

An Update on Methods for Assessing Bone Quality and Health in Cystic Fibrosis

Overview
Specialty Endocrinology
Date 2022 Jan 5
PMID 34984171
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

With increasing life expectancy in people with Cystic fibrosis (CF), the focus of clinical care has shifted to management and prevention of non-pulmonary comorbidities. CF related bone disease, defined by low bone mineral density (BMD), is prevalent across all age groups and acknowledges the increased fractures rates that negatively impact lung function and quality of life. Dual energy X-ray absorptiometry (DXA) measurement of bone mineral content (BMC) and "areal" BMD (aBMD) is recommended for identifying and monitoring bone health in children and adults due to its low cost, low radiation exposure, and widespread availability. Recent studies in children and adolescents with chronic illness focus on adjustment of BMC and aBMD measurements for height due to the effects of short stature and delayed maturation on bone size. Expanded reference databases for alternate imaging sites such as the ultradistal radius and hip present opportunities for research and long-term monitoring. As the two-dimensional nature of DXA imposes limitations, we highlight other imaging modalities including peripheral quantitative computed tomography QCT (pQCT), magnetic resonance imaging, and quantitative ultrasound (QUS). These tools, while primarily used in a research setting, can impart information on true volumetric bone density and bone microarchitecture as well as contribute to fracture assessment and prediction. Due to the high morbidity and mortality associated with vertebral and hip fracture, we will present on vertebral fracture assessment (VFA) in both children and adults as well as applied analyses including hip structural analysis (HSA), trabecular bone score (TBS), and fracture risk assessment (FRAX) for high risk groups. Questions remain on the future clinical applicability and accessibility of these assessment and prediction tools, longitudinal monitoring through adolescence and adulthood, and how outcome measures may guide bone modifying therapies.

Citing Articles

The Impact of Vitamin Deficiencies on Oral Manifestations in Children.

Lesic S, Ivanisevic Z, Spiljak B, Tomas M, Sostaric M, Vcev A Dent J (Basel). 2024; 12(4).

PMID: 38668021 PMC: 11049216. DOI: 10.3390/dj12040109.


Development of the Addenbrooke's MSK screening tool (AMST) for children and adolescents with cystic fibrosis.

Lock K, Nethercott S, Hamilton C, Grace F, Hall N, Lowndes L Heliyon. 2024; 10(4):e25403.

PMID: 38384566 PMC: 10878873. DOI: 10.1016/j.heliyon.2024.e25403.


Effects of Microfiltered Seawater Intake and Variable Resistance Training on Strength, Bone Health, Body Composition, and Quality of Life in Older Women: A 32-Week Randomized, Double-Blinded, Placebo-Controlled Trial.

Juesas A, Gargallo P, Gene-Morales J, Babiloni-Lopez C, Saez-Berlanga A, Jimenez-Martinez P Int J Environ Res Public Health. 2023; 20(6).

PMID: 36981609 PMC: 10048547. DOI: 10.3390/ijerph20064700.


Cystic Fibrosis Bone Disease: The Interplay between CFTR Dysfunction and Chronic Inflammation.

Fonseca O, Gomes M, Amorim M, Gomes A Biomolecules. 2023; 13(3).

PMID: 36979360 PMC: 10046889. DOI: 10.3390/biom13030425.


Bioimpedance and Dual-Energy X-ray Absorptiometry Are Not Equivalent Technologies: Comparing Fat Mass and Fat-Free Mass.

Lopes S, Fontes T, Tavares R, Monteiro Rodrigues L, Ferreira-Pego C Int J Environ Res Public Health. 2022; 19(21).

PMID: 36360820 PMC: 9657485. DOI: 10.3390/ijerph192113940.


References
1.
Chirita-Emandi A, Shepherd S, Kyriakou A, McNeilly J, Dryden C, Corrigan D . A retrospective analysis of longitudinal changes in bone mineral content in cystic fibrosis. J Pediatr Endocrinol Metab. 2017; 30(8):807-814. DOI: 10.1515/jpem-2016-0057. View

2.
Ott S, Aitken M . Osteoporosis in patients with cystic fibrosis. Clin Chest Med. 1998; 19(3):555-67. DOI: 10.1016/s0272-5231(05)70100-3. View

3.
Kindler J, Kalkwarf H, Lappe J, Gilsanz V, Oberfield S, Shepherd J . Pediatric Reference Ranges for Ultradistal Radius Bone Density: Results from the Bone Mineral Density in Childhood Study. J Clin Endocrinol Metab. 2020; 105(10). PMC: 7465545. DOI: 10.1210/clinem/dgaa380. View

4.
Lopez-Rodriguez M, Lavado-Garcia J, Canal-Macias M, Calderon-Garcia J, Moran J, Pedrera-Zamorano J . Quantitative ultrasound in Spanish children and young adults with cystic fibrosis. Biol Res Nurs. 2012; 15(3):280-4. DOI: 10.1177/1099800412441500. View

5.
Bai W, Binkley T, Wallace J, Carver Jr T, Specker B . Peripheral quantitative computed tomography (pQCT) bone measurements in children with cystic fibrosis. Pediatr Pulmonol. 2015; 51(1):28-33. DOI: 10.1002/ppul.23323. View